Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)

TipRanksOct 21 08:41 ET · Ratings

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

GlobeNewswireOct 17 08:00 ET

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Zacks Oct 11 10:05 ET

Morgan Stanley Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Raises Target Price to $95

Moomoo NewsOct 11 08:31 ET · Ratings

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc

Yahoo FinanceOct 10 15:05 ET

Jefferies Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Maintains Target Price $105

Moomoo NewsSep 24 08:31 ET · Ratings